Axcer Molecular Imaging And Therapy Private Limited - Company Profile

It is a healthcare private limited company based in Thane, Maharashtra, India, established in 2021.
2021 Thane, Maharashtra, India Under Process Of Striking Off
Last Updated:
Access Report
About Axcer Molecular Imaging And Therapy Private Limited

Axcer Molecular Imaging And Therapy Private Limited, a under process of striking off private limited company, was established on 28 April 2021 in Thane, Maharashtra, India. Engaging in specialized hospitals within the healthcare sector, it holds CIN: U85110MH2021PTC359621. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹0.10 M.

Its leadership includes Rakesh Onkarchand Katna (Director), Girish Prakash Yevankar (Director). Past directors included Kiran Ameya Puranik. It is based at Flat No 302 3Rd Floor Woodpark Hiranandani Estate Hiranandani Int Road, Thane, Maharashtra, 400607.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110MH2021PTC359621

  • Registration Number

    359621

  • Incorporation Date

    28 April 2021

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Under Process Of Striking Off

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 9 Months
Company report

Axcer Molecular Imaging And Therapy Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Axcer Molecular Imaging And Therapy Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Axcer Molecular Imaging And Therapy Private Limited?
Current Directors
Name Designation Appointment Date Status
Rakesh Onkarchand Katna Director 28 Apr 2021 Current
Girish Prakash Yevankar Director 28 Apr 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 02 Apr 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Axcer Molecular Imaging And Therapy.

Enhance accessibility to Axcer Molecular Imaging And Therapy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Axcer Molecular Imaging And Therapy revenue growth over time
Axcer Molecular Imaging And Therapy profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Axcer Molecular Imaging And Therapy?

Unlock access to Axcer Molecular Imaging And Therapy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Axcer Molecular Imaging And Therapy?

Axcer Molecular Imaging And Therapy has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Axcer Molecular Imaging And Therapy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axcer Molecular Imaging And Therapy's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Axcer Molecular Imaging And Therapy
Recent Activity within the Organization
  • Director Appointment

    The activity Rakesh Onkarchand Katna was appointed as a Director was appointed as a Director on 28 Apr 2021 & has been associated with this company since 4 years 9 months . was completed.

  • Director Appointment

    Progress on Girish Prakash Yevankar was appointed as a Director was appointed as a Director on 28 Apr 2021 & has been associated with this company since 4 years 9 months . was documented.

  • Company Incorporation

    Progress on Axcer Molecular Imaging And Therapy Private Limited was registered on 28 Apr 2021 with Roc Mumbai & aged 4 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Axcer Molecular Imaging And Therapy Private Limited?

The CIN of Axcer Molecular Imaging And Therapy Private Limited is U85110MH2021PTC359621.

Where is Axcer Molecular Imaging And Therapy Private Limited headquartered?

Axcer Molecular Imaging And Therapy Private Limited is headquartered at Flat No 302 3Rd Floor Woodpark Hiranandani Estate Hiranandani Int Road, Thane, Maharashtra, 400607.

When was Axcer Molecular Imaging And Therapy Private Limited incorporated?

Axcer Molecular Imaging And Therapy Private Limited was incorporated on 28 April 2021.

Who are the current directors of Axcer Molecular Imaging And Therapy Private Limited?

The current directors of Axcer Molecular Imaging And Therapy Private Limited are

What is the primary industry of Axcer Molecular Imaging And Therapy Private Limited?

The primary industry of Axcer Molecular Imaging And Therapy Private Limited is Healthcare.

Is Axcer Molecular Imaging And Therapy Private Limited a listed company?

Axcer Molecular Imaging And Therapy Private Limited is unlisted.

What is the capital structure of Axcer Molecular Imaging And Therapy Private Limited?

The authorized capital of Axcer Molecular Imaging And Therapy Private Limited is ₹3.00 Cr, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available